Workflow
Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) closed the last trading session at $9.4, gaining 13.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12 indicates a 27.7% upside potential.The average comprises four short-term price targets ranging from a low of $11.00 to a high of $13.00, with a standard deviation of $0.82. While the lowest estimate indicates an increase of 17% from the current pr ...